In 2023, Croatia leads with $126.4, followed by Switzerland ($68.8) and Canada ($52.2). Austria and Australia show strong year-on-year growth at 9.22% and 8.78%. Declines are notable in Chile (-4.28%), Hungary (-5.54%), and Japan (-2.36%). Year-over-year trends indicate modest to strong growth in key markets, with the United Kingdom and Mexico slightly declining.
Future Trends
Expect advancements in respiratory medicine technology and increasing healthcare awareness to drive higher per capita expenditures, particularly in emerging markets. Monitoring policy changes and economic stability will be crucial in predicting future market dynamics.
Top countries in Respiratory System Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Croatia | 126.4 | 2023 | +0.8% | +2.28% | View data |
| 2 | 2 Switzerland | 68.8 | 2023 | -3.23% | +1.91% | View data |
| 3 | 3 Canada | 52.2 | 2023 | +0.58% | +3.34% | View data |
| 4 | 4 Greece | 47.8 | 2023 | +0.63% | +0.73% | View data |
| 5 | 5 Sweden | 45.7 | 2023 | +0.44% | +1.23% | View data |
| 6 | 6 Austria | 38.7 | 2023 | +8.4% | +9.22% | View data |
| 7 | 7 Spain | 36.7 | 2023 | 0% | +1.66% | View data |
| 8 | 8 Luxembourg | 34.7 | 2023 | +0.29% | +3.16% | View data |
| 9 | 9 Czech Republic | 33.6 | 2023 | +9.8% | +0.36% | View data |
| 10 | 10 Australia | 33.2 | 2023 | +2.15% | +8.78% | View data |
